⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
businesswire.com
AMGN
PFE
Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™
globenewswire.com
BIIB
ALNY
SRPT
JAZZ
PFE
JNJ
BMRN
QURE
AMGN
Dornan Engineering Group expands Executive Leadership Team with four Divisional Managing Directors USA - English USA - español USA - Français USA - English USA - Deutsch
prnewswire.com
CHTR
AMZN
GOOG
MSFT
IBM
VRTX
GILD
AMGN
T
VZ
Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care
accessnewswire.com
WGO
AMGN
LLY
FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease
globenewswire.com
AMGN
CGTN: How does China set tone for economic work in 2026? USA - English USA - English Korea - 한국어
prnewswire.com
BABA
JD
NTES
PDD
BIDU
XPEV
NIO
LI
BYD
AMC
CMG
MCD
SBUX
YUM
COKE
PEP
KHC
MDLZ
COST
WMT
AMZN
GOOG
MSFT
NVDA
INTC
AMD
QCOM
TSM
MU
AAPL
MS
JPM
GS
BAC
WFC
C
V
MA
AXP
BBY
HD
LOW
TJX
ROST
ULTA
LULU
NKE
UA
PVH
RL
HOG
GM
F
STLA
TM
HON
GE
CAT
DE
IBM
ORCL
SAP
CRM
ADBE
NFLX
DIS
CMCSA
VZ
T
TMUS
CHTR
SIRI
PFE
JNJ
MRK
ABBV
BMY
GILD
AMGN
LLY
BIIB
REGN
VRTX
XOM
CVX
SHEL
TTE
COP
MPC
VLO
ET
KMI
NEE
DUK
SO
EXC
AEP
SRE
PCG
ED
XEL
WEC
EIX
D
PNW
CMS
CEG
NRG
ECL
LIN
APD
DD
DOW
MMM
BA
LMT
RTX
GD
NOC
AVGO
TXN
ADI
NXPI
MRVL
ON
MCHP
ALGN
ISRG
MDT
SYK
ZBH
BAX
EW
TFX
AZN
BNTX
CRSP
EDIT
NTLA
CPRT
AZO
ORLY
LAD
CAR
AVTR
ILMN
DXCM
GOOGL
META
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
prnewswire.com
AMGN
Fusion Proteins Market to Hit $64.9 Billion by 2030
globenewswire.com
AMGN
BMY
PFE
MRK
Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer
globenewswire.com
AMGN
SNY
AZN
Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
TAK
AMGN
JNJ
BMY